We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
KBR
KBR
$4.68B
| $12.8M | 0.18% |
513,712
-109,378
| -18% | -$2.45M |
|
152
Broadcom
AVGO
$1.82T
| $12.8M | 0.18% |
+444,270
| New | +$12.9M |
|
153
Booking.com
BKNG
$138B
| $12.7M | 0.18% |
169,825
+5,325
| +3% | +$383K |
|
|
AMTD
154
DELISTED
TD Ameritrade Holding Corp
AMTD
| $12.7M | 0.18% |
255,110
+100,120
| +65% | +$5.19M |
|
155
Arista Networks
ANET
$219B
| $12.7M | 0.18% |
781,760
+176,656
| +29% | +$3.06M |
|
156
Cummins
CMI
$91.7B
| $12.5M | 0.17% |
72,990
+65,510
| +876% | +$10.7M |
|
157
Benchmark Electronics
BHE
$2.91B
| $12.4M | 0.17% |
492,452
+58,910
| +14% | +$1.51M |
|
158
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $12.3M | 0.17% |
363,046
-14,460
| -4% | -$534K |
|
|
NAV
159
DELISTED
Navistar International
NAV
| $12.2M | 0.17% |
353,775
-96,390
| -21% | -$3.2M |
|
160
Peabody Energy
BTU
$2.78B
| $12.1M | 0.17% |
502,764
+65,850
| +15% | +$1.73M |
|
161
Dell
DELL
$283B
| $12.1M | 0.17% |
468,134
+374,989
| +403% | +$11.7M |
|
162
Innospec
IOSP
$2.09B
| $12M | 0.17% |
131,603
+101,065
| +331% | +$8.52M |
|
163
Cisco
CSCO
$450B
| $12M | 0.17% |
218,780
-51,540
| -19% | -$2.85M |
|
|
TSE
164
DELISTED
Trinseo
TSE
| $11.8M | 0.16% |
279,873
+10,670
| +4% | +$458K |
|
165
Pentair
PNR
$10.2B
| $11.8M | 0.16% |
317,310
-2,560
| -0.8% | -$97.1K |
|
166
Synaptics
SYNA
$4.41B
| $11.8M | 0.16% |
404,870
-25,050
| -6% | -$817K |
|
167
Varonis Systems
VRNS
$5.25B
| $11.8M | 0.16% |
569,358
+62,430
| +12% | +$1.34M |
|
168
Meta Platforms (Facebook)
META
$1.51T
| $11.6M | 0.16% |
60,017
+6,750
| +13% | +$1.23M |
|
169
Hancock Whitney
HWC
$6.13B
| $11.5M | 0.16% |
287,456
+20,210
| +8% | +$833K |
|
170
Palo Alto Networks
PANW
$264B
| $11.5M | 0.16% |
338,358
+122,898
| +57% | +$4.6M |
|
171
Commerce Bancshares
CBSH
$8.5B
| $11.4M | 0.16% |
269,799
-17,130
| -6% | -$722K |
|
172
Neurocrine Biosciences
NBIX
$17.7B
| $11.3M | 0.16% |
134,379
+50,210
| +60% | +$4.12M |
|
173
Pinnacle West Capital
PNW
$12.9B
| $11.3M | 0.16% |
120,440
-3,310
| -3% | -$315K |
|
174
FMC
FMC
$1.42B
| $11.2M | 0.16% |
+135,415
| New | +$10.6M |
|
175
Visteon
VC
$2.77B
| $11M | 0.15% |
188,448
+155,522
| +472% | +$9.5M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.